晚期卵巢癌初次肿瘤细胞减灭术的持续改进:完全肉眼切除率提高是否独立带来无进展生存期和总生存期延长
本研究纳入2001年至2013年在本机构接受初次肿瘤细胞减灭术的978例IIIB-IV期高级别卵巢癌患者,按手术范式变革分为三组。完全肉眼切除率从29%升至40%再升至55%(p<0.001),5年总生存率从40%升至44%再升至56%(p<0.001),5年无进展生存率分别为15%、16%、20%(p=0.199)。多因素分析显示完全肉眼切除与无进展生存期和总生存期独立相关(均p<0.001)。
要点
- 完全肉眼切除率在三组间从29%升至40%再升至55%(p<0.001)。
- 5年总生存率从40%升至44%再升至56%(p<0.001),5年无进展生存率15%、16%、20%(p=0.199)。
- 多因素分析示完全肉眼切除与无进展生存期和总生存期独立相关(均p<0.001)。
核心结论
- 尽管晚期患者疾病分期更高、肿瘤负荷更大,13年间初次肿瘤细胞减灭术的完全肉眼切除率、无进展生存期和总生存期均提高。
- 作者认为,为实现更彻底手术细胞减灭而实施的手术范式转变可能是这些改善的原因。
研究设计与样本
- 回顾性分析2001年1月至2013年12月在本机构接受初次肿瘤细胞减灭术、以最大程度细胞减灭为目标的IIIB-IV期高级别卵巢癌患者978例。
- 按手术范式变革实施年份分为三组:第1组2001-2005年,第2组2006-2009年,第3组2010-2013年。
主要发现
- 978例中78%为IIIC期,89%为浆液性组织学,81%存在癌病,60%有上腹部大块病变。
- 与第1组相比,后两个时间段接受初次肿瘤细胞减灭术者ASA评分更高(p<0.001)、分期更高(p<0.001)、更常有癌病(p=0.015)和上腹部大块病变(p=0.009)。
- 第1至3组完全肉眼切除率分别为29%、40%、55%(p<0.001)。
- 第1至3组5年无进展生存率分别为15%、16%、20%(p=0.199),5年总生存率分别为40%、44%、56%(p<0.001)。
- 多因素分析中完全肉眼切除与无进展生存期独立相关(p<0.001),与总生存期独立相关(p<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess complete gross resection (CGR) rates and survival outcomes in patients with advanced ovarian cancer who underwent primary debulking surgery (PDS) during a 13-year period in which specific changes to surgical paradigm were implemented. METHODS: We identified all patients with stage IIIB-IV high-grade ovarian carcinoma who underwent PDS at our institution, with the intent of maximal cytoreduction, from 1/2001-12/2013. Patients were categorized by year of PDS based on the implementation of surgical changes to our approach to ovarian cancer debulking (Group 1, 2001-2005; Group 2, 2006-2009; Group 3, 2010-2013). RESULTS: Among 978 patients, 78% had stage IIIC disease and 89% had disease of serous histology. Carcinomatosis was found in 81%, and 60% had bulky upper abdominal disease (UAD). Compared to Group 1, those who underwent PDS during the latter 2 time periods had higher ASA scores (p < 0.001), higher-stage disease (p < 0.001), and more often had carcinomatosis (p = 0.015) and bulky UAD (p = 0.009). CGR rates for Groups 1-3 increased from 29% to 40% to 55%, respectively (p < 0.001). Five-year progression-free survival (PFS) rates increased over time (15%, 16%, and 20%, respectively; p = 0.199), as did 5-year overall survival (OS) rates (40%, 44%, and 56%, respectively; p < 0.001). On multivariable analysis, CGR was independently associated with PFS (p < 0.001) and OS (p < 0.001). CONCLUSIONS: Despite higher-stage disease and greater tumor burden, CGR rates, PFS and OS for patients who underwent PDS increased over a 13-year period. Surgical paradigm shifts implemented specifically to achieve more complete surgical cytoreduction are likely the reason for these improvements.
引用
- Tseng JH, Cowan RA, Zhou Q, et al. Continuous improvement in primary Debulking surgery for advanced ovarian cancer: Do increased complete gross resection rates independently lead to increased progression-free and overall survival? Gynecol Oncol. 2018. PMID: 30126704. doi:10.1016/j.ygyno.2018.08.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。